The US Food and Drug Administration (FDA) has approved the first single-entity extended-release formulation of hydrocodone bitartrate (Zohydro ER, Zogenix Inc) for the management of pain severe enough ...
Abuse-deterrent single-entity hydrocodone products are edging closer to market. Purdue Pharma LP has announced that the US Food and Drug Administration (FD) has granted Priority Review designation for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results